2,150 research outputs found

    On Love, Covid, and Scholarship

    Get PDF

    INTRODUCTION Deep Roots, Rich Legacies: Honoring Fifty Years of Scholar-Activism

    Get PDF

    Evidence That Luminant and Equiluminant Motion Signals Are Integrated by Directionally Selective Mechanisms

    Get PDF
    Three experiments tested whether motion information for nonequiluminant (luminant) and equiluminant dots affects direction judgments when both types of stimuli are moving simultaneously in the same display. The motion directions for the two sets of dots were manipulated to produce four direction differences (0Β°, 30Β°, 60Β°, and 90Β°). The equiluminant dots were moved in a perfectly correlated fashion, but the percentage of correlated motion for the luminant dots was varied. When subjects judged whether the directions of the equiluminant and luminant dots were the same or different, performance for the conditions with 0Β°, 60Β°, and 90Β° difference improved as the percentage of correlated luminant motion increased. The same result occurred for a control display that contained two sets of luminant dots. However, for the 30Β° difference, performance was at chance level for the control display, but dropped below chance for the equiluminant - luminant display. When subjects indicated just the direction of the luminant dots, judgments were not affected by equiluminant motion. Judgments for the equiluminant dots also were accurate, except for the conditions with 30Β° difference; these responses were biased by the luminant motion, indicating some form of motion capture. The interactive effects are discussed in terms of a directionally selective mechanism that combines equiluminant and luminant motion signals

    Non-linear rheology of active particle suspensions: Insights from an analytical approach

    Full text link
    We consider active suspensions in the isotropic phase subjected to a shear flow. Using a set of extended hydrodynamic equations we derive a variety of {\em analytical} expressions for rheological quantities such as shear viscosity and normal stress differences. In agreement to full-blown numerical calculations and experiments we find a shear thickening or -thinning behaviour depending on whether the particles are contractile or extensile. Moreover, our analytical approach predicts that the normal stress differences can change their sign in contrast to passive suspensions.Comment: 11 pages, 10 figures, appear in PR

    Hydrodynamic length-scale selection in microswimmer suspensions

    Get PDF
    A universal characteristic of mesoscale turbulence in active suspensions is the emergence of a typical vortex length scale, distinctly different from the scale invariance of turbulent high-Reynolds number flows. Collective length-scale selection has been observed in bacterial fluids, endothelial tissue, and active colloids, yet the physical origins of this phenomenon remain elusive. Here, we systematically derive an effective fourth-order field theory from a generic microscopic model that allows us to predict the typical vortex size in microswimmer suspensions. Building on a self-consistent closure condition, the derivation shows that the vortex length scale is determined by the competition between local alignment forces, rotational diffusion, and intermediate-range hydrodynamic interactions. Vortex structures found in simulations of the theory agree with recent measurements in Bacillus subtilis suspensions. Moreover, our approach yields an effective viscosity enhancement (reduction), as reported experimentally for puller (pusher) microorganisms

    Ising-like critical behavior of vortex lattices in an active fluid

    Full text link
    Turbulent vortex structures emerging in bacterial active fluids can be organized into regular vortex lattices by weak geometrical constraints such as obstacles. Here we show, using a continuum-theoretical approach, that the formation and destruction of these patterns exhibit features of a continuous second-order equilibrium phase transition, including long-range correlations, divergent susceptibility, and critical slowing down. The emerging vorticity field can be mapped onto a two-dimensional (2D) Ising model with antiferromagnetic nearest-neighbor interactions by coarse-graining. The resulting effective temperature is found to be proportional to the strength of the nonlinear advection in the continuum model

    Disruption of a Yeast ADE6 Gene Homolog in Ustilago maydis

    Get PDF
    A putative homolog of the Sacharromyces cereviseae ADE6 and Escherichia coli purL genes is identified near a multigenic complex, which contains two genes, sid1 and sid2, involved in a siderophore biosynthetic pathway inUstilago maydis. The putative ADE6 homolog was mutated by targeted gene disruption. The resulting mutant strains demonstrated a requirement for exogenous adenine, indicating that the U. maydis ade6 homolog is required for purine biosynthesis

    Clinical impact of MDR1-expression in testicular germ cell cancer

    No full text
    Aim: The multidrug resistance protein 1 (MDR1, P-gp, p-170) is a membrane glycoprotein that acts as an energy-dependent drug efflux pump. In various malignancies its expression is associated with resistance to diverse cytostatic drugs, and therefore predicts resistance to systemic treatment. The aim of this study was to investigate the prognostic value of MDR1 expression in primary tumor tissue to predict necrosis or viable cancer in residual tumor masses after systemic chemotherapy for advanced testicular germ cell cancer. Materials and Methods: Out of 77 patients, histopathological characteristics of primary testicular cancer specimens and retroperitoneal lymph node dissection (RPLND) samples following chemotherapy were available from 72 and all 77 patients, respectively. Moreover, MDR1 expression was determined by immunohistochemistry in 47 primary tumors and corresponding 73 RPLND sections. Results: After chemotherapy and subsequent RPLND, the examination of residual tumor masses revealed that mature teratoma and active viable tumor were predominantly found in patients with non-seminoma (NSGCT; p = 0.048), especially in those with containing mature teratoma (p = 0.001). Moreover, using univariate analysis the expression of MDR1 in the primary testicular tumor predicted viable tumor/teratoma residues in RPLND sections (p = 0.003). However, in multivariate analysis including the tumors’ histological subtype, MDR1 expression alone failed to reach statistical significance as an independent prognostic marker for residual vital tumor (p β‰₯ 0.16). Conclusions: With the limited number of patients given, the correlation between MDR1 expression in primary testis cancer and active residual retroperitoneal disease after chemotherapy failed to reach statistical significance as in independent marker. Therefore, up to now routine MDR1 staining of testicular germ cell cancer samples should not be performed in clinical practice. However, as there was a clear trend, a larger number of patients suffering from metastatic non-seminomas should be studied, as MDR1 expression might have significant prognostic value in this particular subgroup of patients.Π‘Π΅Π»ΠΎΠΊ 1 мноТСствСнной лСкарств Π΅Π½Π½ΠΎΠΉ устойчив ости (MDR1, P-gp, p-170) – это ΠΌΠ΅ΠΌΠ±Ρ€Π°Π½Π½Ρ‹ΠΉ Π³Π»ΠΈΠΊΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΈΠ½, Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠΉ ΠΊΠ°ΠΊ энСргозависимый насос. ΠŸΡ€ΠΈ Ρ€Π°Π·Π» ΠΈΡ‡Π½Ρ‹Ρ… Ρ„ΠΎ Ρ€ΠΌΠ°Ρ… ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ Π΅Π³ΠΎ экспр Π΅ ссия связана с устойчив ΠΎ ΡΡ‚ΡŒΡŽ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΊ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹ΠΌ цитостатикам, Ρ‡Ρ‚ΠΎ ΠΌΠΎΠΆΠ΅Ρ‚ Π±Ρ‹Ρ‚ΡŒ использовано для Π²Ρ‹Π±ΠΎΡ€Π° Ρ‚ΠΈΠΏΠ° Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. ЦСль Ρ€Π°Π±ΠΎΡ‚Ρ‹ β€” исслСдованиС прогности- чСской значимости экспрСссии MDR1 Π² Ρ‚ΠΊΠ°Π½ΠΈ ΠΏΠ΅ Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ для ΠΎΡ†Π΅Π½ΠΊΠΈ Π²ΠΎΠ·ΠΌΠΎ Тности Ρ€Π°Π· вития Π½Π΅ΠΊΡ€ΠΎΠ·Π° ΠΈΠ»ΠΈ сохран Π΅ ния ΠΆΠΈΠ²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ Π² остаточной Ρ‚ΠΊΠ°Π½ΠΈ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ послС примСнСния систСмной Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π½Π° ΠΏΠΎΠ·Π΄Π½ΠΈΡ… стадиях Π³Π΅Ρ€ΠΌΠΈΠ½Π°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ яичка. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹: ΠΏΡ€ΠΎ Π°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎ Π²Π°Π½Ρ‹ гисто ΠΏΠ°Ρ‚ΠΎΠ»ΠΎ гичСскиС Ρ…Π°Ρ€Π°ΠΊΡ‚ Π΅ ристики ΠΏΠ΅ Ρ€Π²ΠΈΡ‡Π½ΠΎ ΠΉ Ρ‚Π΅ стикулярной ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΈ ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ², ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Ρ… ΠΏΡ€ΠΈ иссСчСнии Ρ€Π΅Ρ‚Ρ€ΠΎΠΏΠ΅Ρ€ΠΈΡ‚ΠΎΠ½Π΅Π°Π»ΡŒΠ½Ρ‹Ρ… лимфатичСских ΡƒΠ·Π»ΠΎΠ² (RPLND) послС Ρ…ΠΈΠΌΠΈ ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ 72 ΠΈ 77 Π±ΠΎΠ» ΡŒΠ½Ρ‹Ρ… соотвС тствСнно. Экспр Сссию MDR1 опрСдСляли ΠΈΠΌΠΌΡƒΠ½ огист ΠΎΡ…ΠΈΠΌΠΈΡ‡ Сским ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ Π² 47 ΠΎΠ±Ρ€Π°Π·Ρ†Π°Ρ… ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΈ ΡΠΎΠΎΡ‚Π²Π΅Ρ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… 73 ср RPLND. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹: послС Ρ…ΠΈΠΌΠΈ ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΉ RPLNDисслСдовани Π΅ оста- Ρ‚ΠΎΡ‡Π½Ρ‹Ρ… ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Ρ… Ρ‚ΠΊΠ°Π½Π΅ΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ, чтозрСлая Ρ‚Π΅Ρ€Π°Ρ‚ΠΎΠΌΠ° ΠΈ ТизнСспособныС ΠΎΠΏΡƒΡ… ΠΎΠ»Π΅Π²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ выяв Π»ΡΡŽΡ‚ прСимущСствСнно Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…, Ρƒ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π½Π΅ Π±Ρ‹Π»Π° ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½Π° сСминома (NSGCT; p = 0,048), особСнно Ρƒ Ρ‚Π°ΠΊ ΠΎΠ²Ρ‹Ρ… , Ρƒ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π±Ρ‹Π»Π° Ρ‚Π΅Ρ€Π°Ρ‚ΠΎΠΌΠ° (p = 0,001). Π‘ΠΎΠ»Π΅Π΅ Ρ‚ΠΎΠ³ΠΎ, Π΄ Π°Π½Π½Ρ‹Π΅ ΠΎΠ΄Π½ΠΎ Ρ„Π°ΠΊΡ‚ΠΎΡ€Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, Ρ‡Ρ‚ΠΎ экспр Π΅ ссия MDR1 Π² Ρ‚ΠΊΠ°Π½ΠΈ ΠΏΠ΅ Ρ€Π²ΠΈΡ‡Π½ΠΎ ΠΉ Ρ‚Π΅ стику лярной ΠΎΠΏΡƒ- Ρ…ΠΎΠ»ΠΈ ΠΌΠΎΠΆΠ΅Ρ‚ ΡΠ»ΡƒΠΆΠΈΡ‚ΡŒ прогностич Сским Ρ„Π°ΠΊΡ‚ ΠΎΡ€ΠΎΠΌ сохран Сния ΠΆΠΈΠ²Ρ‹Ρ… ΠΎΠΏΡƒΡ… ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ срСзах RPLND (p = 0,003). О Π½Π°ΠΊ ΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡ„Π°ΠΊΡ‚ΠΎΡ€Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°, Π² Ρ‚ΠΎΠΌ числС с ΡƒΡ‡Π΅Ρ‚ΠΎΠΌ гистологичСского ΠΏΠΎΠ΄Ρ‚ΠΈΠΏΠ° ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ, ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ, Ρ‡Ρ‚ΠΎ экспр Π΅ ссия MDR1 Π½Π΅ ΠΈΠΌΠ΅Π΅Ρ‚ ΡΠ°ΠΌΠΎΡΡ‚ΠΎΡΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ прогностичСской значимости для выявлСния ΠΆΠΈΠ²Ρ‹Ρ… остаточных ΠΎΠΏΡƒΡ… ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ (p 0,16). Π’Ρ‹Π²ΠΎΠ΄Ρ‹: Π²Π²ΠΈΠ΄Ρƒ нСбольшо ΠΉΠ²Ρ‹Π±ΠΎΡ€ΠΊΠΈΠ±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π½Π΅ выяв Π»Π΅Π½ΠΎ статистичСски значимойкоррСляции ΠΌΠ΅ΠΆΠ΄Ρƒ экспр СссиСй MDR1 Π² ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ яичка ΠΈ Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ΠΌ Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… Ρ€Π΅Π·ΠΈΠ΄ΡƒΠ°Π»ΡŒΠ½Ρ‹Ρ… ΠΎΡ‡Π°Π³ΠΎΠ² пораТСния Π² Ρ€Π΅Ρ‚Ρ€ΠΎΠΏΠ΅Ρ€ΠΈΡ‚ΠΎΠ½Π΅Π°Π»ΡŒΠ½ΠΎΠΌ пространствС. Π’ Ρ‚ ΠΎ ΠΆΠ΅ врСмя, учитывая Π²Ρ‹ΡΠ²Π»Π΅Π½Π½ΡƒΡŽ Ρ‚Π΅Π½Π΄Π΅Π½Ρ†ΠΈΡŽ, ΡΠΊΡΠΏΡ€Π΅ΡΡΠΈΡŽ MDR1, Π² качСствС Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ прогностич Сского ΠΌΠ°Ρ€ΠΊ Π΅Ρ€Π°, ΠΈΠΌΠ΅Π΅Ρ‚ смысл ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Ρ‚ΡŒ ΠΈΠΌΠ΅Π½Π½ΠΎ Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… с мСтастатичСскими опухолями, Π½Π΅ ΡΠ²Π»ΡΡŽΡ‰ΠΈΠΌΠΈΡΡ сСминомой
    • …
    corecore